drugset / Trial / NCT00738777

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

NCT00738777

RandomizedParallel-groupOpen-labelBasic science

Summary

To investigate prospectively whether short term endocrine treatment can induce molecular changes, predictive for therapy response.

Timeline

Start
2008-07
Primary completion
2022-06
Completion
2024-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Anastrozole Other / unclassified 1 mg Oral
Subject Fulvestrant Small molecule 500 mg Intramuscular
Subject Tamoxifen Small molecule 20 mg Oral

Indications